Approvals/TGA/EVOCAIR ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack

Approved

STANDARD

EVOCAIR ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f808dfe71c1fb07e
Product Name: EVOCAIR ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack
Artg Id: 208196
Artg Name: EVOCAIR ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2014-05-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f808dfe71c1fb07e

Type

Standard